维普中文期刊产品整合服务
28篇 您的检索式:作者名="DOMAGALA T"
    题名 作者 年代 出处 被引量
1The clinical significance of p53 accumulation in gastric carcinoma显示文摘Starzynska T Markiewski M Domagala W 1996Cancer1996,77,10:1
2Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3显示文摘 Roufail S Domagala T 2000Eur J Biochem2000,267,9:1
3Rapid microscale enzymic semisynthesis of epidermal growth factor (EGF) analogues显示文摘NICE EC DOMAGALA T FABRI L 2002Growth Factors2002,20,2:1
4The clinical significance of p53 accumulation in gastric carcinoma显示文摘Starzynska T Markiewski M Domagala W 1996Cancer1996,77,10:1
5PARP -1 expression in breast cancer including brcal -associated, tri- ple negative and basal -like tumors: possible implications for parp - 1 inhibitor therapy 显示文摘DOMAGALA P HUZARSKI T LUBINSKI J 2011Breast Cancer Res Treat2011,127,3:1
6The clinical significance of p53 accumulation in gastric carcinoma显示文摘Starzynska T Markiewski M Domagala W 1996Cancer1996,77,10:1
7New 7-substituted quinolone antibacterial agents显示文摘Culbertson T P Domagala J M Peterson P 1987Heterocycl Chem1987,24,:1
8Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3显示文摘ACHEN M G ROUFAIL S DOMAGALA T 2000Eur J Biochem2000,267,9:1
9The clinical significance of-p53 accumulation in gastric carcinoma 显示文摘Starzynska T Markiewski M Domagala W 1996Cancer1996,77,10:1
10Quinolone anti- bacterials containing the new 7- side chain: The effect of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy 显示文摘Domagala JM Hagen SE Joannides T 1993J Med Chem1993,36,:1
11PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumom : possible implications for PARP-1 inhibitor therapy显示文摘Domagala P Huzarski T Lubinski J 2011Breast Cancer Res Treat2011,127,3:1
12PARP-1 expression in breast cancer including BRCAl-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor ther- apy显示文摘Domagala P Huzarski T Lubinski J 2011Breast Cancer Res Treat2011,127,3:1
13Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEHF receptor-2 and VEGF receptor-3显示文摘Achen MG Roufail S Domagala T 2000Eur J Biochem2000,267,9:1
14The clinical significance of p53 accumulation in gastric carcinoma显示文摘Starzynska T Markiewski M Domagala W 1996Cancer1996,77,10:1
15Mutant prevention concentration as a measure of fluoroquinolone potency againstmy cobacteria显示文摘Sindelar G Zhao X Liew A Dong YZ Lu T Zhou JF Domagala J Drlica K 2000Antimicrob A gents Chemother2000,44,12:1
162007, Changes in texture of yoghurt from goat' s milk modified by transglu-taminase depending on pH of the milk显示文摘Domagala J Sady M Grega T Najgebauer-Lejko D 2007Biotech- nology in Animal Husbandry2007,23,56:1
17Monoclonal antibodies to vascular endothelial growth factor D block interactions with both VEGF receptor-2 and VFGF receptor-3 显示文摘Achen MG Roufail S Domagala T 2000Eur J Brichem2000,267,4:1
18显示文摘Culbertson T P Domagala J M Peterson P 1987J Heterocycl Chem1987,24,8:1
19PARP- 1expression in breast cancer including BRCAl-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy显示文摘Domagala P Huzarski T Lubinski J 2011Breast Cancer Res Treat2011,127,3:1
20PARP-1 expression in breast cancer including BRCA1-associated, triple negative and bas- M-like tumors:possible implications for PARP-1 inhibitor therapy 显示文摘Domagala P Huzarski T Lubinski J 2011Breast Cancer Res Treat2011,127,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费